168 related articles for article (PubMed ID: 9045633)
1. Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition.
Côté HC; Bajzar L; Stevens WK; Samis JA; Morser J; MacGillivray RT; Nesheim ME
J Biol Chem; 1997 Mar; 272(10):6194-200. PubMed ID: 9045633
[TBL] [Abstract][Full Text] [Related]
2. Calcium ion modulation of meizothrombin autolysis at Arg55-Asp56 and catalytic activity.
Stevens WK; Côté HF; MacGillivray RT; Nesheim ME
J Biol Chem; 1996 Apr; 271(14):8062-7. PubMed ID: 8626490
[TBL] [Abstract][Full Text] [Related]
3. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
Mosnier LO
J Biol Chem; 2011 Jan; 286(1):502-10. PubMed ID: 21041299
[TBL] [Abstract][Full Text] [Related]
4. Multiple active forms of thrombin. IV. Relative activities of meizothrombins.
Doyle MF; Mann KG
J Biol Chem; 1990 Jun; 265(18):10693-701. PubMed ID: 2355015
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of meizothrombin and meizothrombin(desF1) by heparin cofactor II.
Han JH; Côté HC; Tollefsen DM
J Biol Chem; 1997 Nov; 272(45):28660-5. PubMed ID: 9353333
[TBL] [Abstract][Full Text] [Related]
6. A recombinant murine meizothrombin precursor, prothrombin R157A/R268A, inhibits thrombosis in a model of acute carotid artery injury.
Shim K; Zhu H; Westfield LA; Sadler JE
Blood; 2004 Jul; 104(2):415-9. PubMed ID: 15039280
[TBL] [Abstract][Full Text] [Related]
7. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
Bajzar L; Nesheim M; Morser J; Tracy PB
J Biol Chem; 1998 Jan; 273(5):2792-8. PubMed ID: 9446587
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A).
Côté HC; Stevens WK; Bajzar L; Banfield DK; Nesheim ME; MacGillivray RT
J Biol Chem; 1994 Apr; 269(15):11374-80. PubMed ID: 8157669
[TBL] [Abstract][Full Text] [Related]
9. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
10. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells.
Wu C; Kim PY; Swystun LL; Liaw PC; Weitz JI
J Thromb Haemost; 2016 Feb; 14(2):366-74. PubMed ID: 26663133
[TBL] [Abstract][Full Text] [Related]
11. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
Marar TT; Boffa MB
J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
[TBL] [Abstract][Full Text] [Related]
12. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
van Moorsel MVA; Poolen GC; Koekman CA; Verhoef S; de Maat S; Barendrecht A; van Kleef ND; Meijers JCM; Schiffelers RM; Maas C; Urbanus RT
J Thromb Haemost; 2022 May; 20(5):1213-1222. PubMed ID: 35170225
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
Binette TM; Taylor FB; Peer G; Bajzar L
Blood; 2007 Nov; 110(9):3168-75. PubMed ID: 17644733
[TBL] [Abstract][Full Text] [Related]
14. The in situ inhibition of prothrombinase-formed human alpha-thrombin and meizothrombin(des F1) by antithrombin III and heparin.
Schoen P; Lindhout T
J Biol Chem; 1987 Aug; 262(23):11268-74. PubMed ID: 3611110
[TBL] [Abstract][Full Text] [Related]
15. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587
[TBL] [Abstract][Full Text] [Related]
16. Binding of hirudin to meizothrombin.
Fischer BE; Schlokat U; Himmelspach M; Dorner F
Protein Eng; 1998 Aug; 11(8):715-21. PubMed ID: 9749925
[TBL] [Abstract][Full Text] [Related]
17. Activation of human factor V by meizothrombin.
Tans G; Nicolaes GA; Thomassen MC; Hemker HC; van Zonneveld AJ; Pannekoek H; Rosing J
J Biol Chem; 1994 Jun; 269(23):15969-72. PubMed ID: 8206891
[TBL] [Abstract][Full Text] [Related]
18. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
Hosaka Y; Takahashi Y; Ishii H
Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
[TBL] [Abstract][Full Text] [Related]
19. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains.
Hall SW; Nagashima M; Zhao L; Morser J; Leung LL
J Biol Chem; 1999 Sep; 274(36):25510-6. PubMed ID: 10464282
[TBL] [Abstract][Full Text] [Related]
20. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.
Bajzar L; Morser J; Nesheim M
J Biol Chem; 1996 Jul; 271(28):16603-8. PubMed ID: 8663147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
